SCHEMBL803268

SCHEMBL803268

CN(C(=O)CC1CCCC1)[C@@H]1CCc2ccc(C(=O)O)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
XBP1 P17861 1/20 0.42
HTT P42858 1/20 0.42
NAMPT P43490 1/20 0.40
DRD3 P35462 1/20 0.40
TMEM97 Q5BJF2 2/20 0.39
ACHE P22303 2/20 0.39
SIGMAR1 Q99720 1/20 0.39
MCHR1 Q99705 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785380 1.00 ALDH1A1 (0.42) ALDH1A1XBP1HTTNAMPTDRD3
SCHEMBL784750 0.88 ALDH1A1 (0.40) ALDH1A1XBP1HTTDRD3TMEM97
SCHEMBL784751 0.88 ALDH1A1 (0.40) ALDH1A1XBP1HTTDRD3TMEM97
SCHEMBL803741 0.87 NAMPT (0.45) ALDH1A1XBP1HTTNAMPTDRD3
SCHEMBL784567 0.81 ALDH1A1 (0.41) ALDH1A1XBP1HTTDRD3ACHE
SCHEMBL784565 0.81 ALDH1A1 (0.41) ALDH1A1XBP1HTTDRD3ACHE
SCHEMBL785634 0.80 DRD3 (0.39) ALDH1A1XBP1HTTDRD3TMEM97
SCHEMBL803298 0.80 DRD3 (0.39) ALDH1A1XBP1HTTDRD3TMEM97
SCHEMBL13131171 0.79 ACHE (0.57) ALDH1A1DRD3ACHEMCHR1RXRA
SCHEMBL803230 0.77 MEN1 (0.40) ALDH1A1XBP1HTTNAMPTTMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 ALDH1A1 1267/4885XBP1 3609/4885HTT 2709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.